0001726100-17-000001.txt : 20171222 0001726100-17-000001.hdr.sgml : 20171222 20171222134911 ACCESSION NUMBER: 0001726100-17-000001 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20171222 DATE AS OF CHANGE: 20171222 EFFECTIVENESS DATE: 20171222 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elysium Therapeutics, Inc. CENTRAL INDEX KEY: 0001726100 IRS NUMBER: 462769808 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-301555 FILM NUMBER: 171272196 BUSINESS ADDRESS: STREET 1: 9000 CROW CANYON ROAD, STE. 620 CITY: DANVILLE STATE: CA ZIP: 94506 BUSINESS PHONE: (925) 399-7246 MAIL ADDRESS: STREET 1: 9000 CROW CANYON ROAD, STE. 620 CITY: DANVILLE STATE: CA ZIP: 94506 D 1 primary_doc.xml X0708 D LIVE 0001726100 Elysium Therapeutics, Inc. 9000 CROW CANYON ROAD, STE. 620 DANVILLE CA CALIFORNIA 94506 (925) 399-7246 DELAWARE None None Corporation true 2013 Alex Gregory Sturmer c/o Elysium Therapeutics, Inc. 9000 CROW CANYON RD., STE. 620 DANVILLE CA CALIFORNIA 94506 Executive Officer Director Thomas E. Jenkins c/o Elysium Therapeutics, Inc. 9000 CROW CANYON RD., STE. 620 DANVILLE CA CALIFORNIA 94506 Executive Officer Director Kathy LaPorte c/o Elysium Therapeutics, Inc. 9000 CROW CANYON RD., STE. 620 DANVILLE CA CALIFORNIA 94506 Director Bob Rappaport c/o Elysium Therapeutics, Inc. 9000 CROW CANYON RD., STE. 620 DANVILLE CA CALIFORNIA 94506 Director Biotechnology Decline to Disclose 06b false 2017-12-08 false true false 1 1500000 651778 848222 false 14 0 0 40000 true Wages to CEO. false Elysium Therapeutics, Inc. /s/ A. Gregory Sturmer A. Gregory Sturmer President & CEO 2017-12-22